24 results match your criteria: "Pseudohypoglycemia"
Background: Glucose levels are vital for indicating the body's sugar content, with imbalances leading to diseases like diabetes or hypoglycemia-related symptoms such as palpitations and fatigue.
Methods: This case series describes three cases of hypoglycemia identified in recent years, utilizing multiple glucose measurement methods and exploring strategies to eliminate interferences.
Results: Two cases of pseudo-hypoglycemia induced by PEGylated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) and Evolocumab injections, and one case of true reactive hypoglycemia following a glucose tolerance test in a patient post-gastric bypass surgery.
Heliyon
June 2024
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Pegylated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) is an effective treatment for chemotherapy-induced neutropenia. However, it can also induce various adverse effects, including fever, bone pain, and other discomforts arising from the abnormal proliferation of blood cells. This study presents an analysis of a case involving a middle-aged patient with small cell lung cancer who exhibited transiently low blood glucose levels without experiencing any symptoms of hypoglycemia following PEG-rhG-CSF treatment.
View Article and Find Full Text PDFR I Med J (2013)
February 2024
Division of Pulmonary, Critical Care and Sleep Medicine, Care New England Health System; The Warren Alpert Medical School of Brown University, Providence, RI.
Turk Arch Pediatr
March 2023
Department of Pediatric Endocrinology and Diabetes, Koç University Hospital, İstanbul, Turkey; Division of Pediatric Endocrinology and Diabetes, Koç University Faculty of Medicine, İstanbul Turkey.
Clin Biochem
May 2023
Department of Laboratory Medicine, Cleveland Clinic, Cleveland, OH, USA. Electronic address:
The preanalytical phase of testing accounts for the majority of the errors. Software-based quality rules, such as autoverification, can assist in preanalytical error detection; therefore, preventing erroneous results from being reported. Two autoverification rules, turbidity/lipemia, and pseudohypoglycemia/pseudohyperkalemia alarms, are highlighted.
View Article and Find Full Text PDFAACE Clin Case Rep
November 2020
Department of Internal Medicine, Wellstar Atlanta Medical Center, Atlanta, Georgia.
Objective: To create awareness among health care professionals and nurses regarding interference with point-of-care (POC) blood glucose (BG) meter by high-dose intravenous vitamin C and other potential substances. We report a case that probably resulted in the death of a patient from an erroneous interpretation of POC-BG readings due to interference from high-dose vitamin C.
Methods: Retrospective case review.
Emergencias
June 2016
Servicio de Urgencias Generales, Hospital de Basurto, Bilbao, España. Departamento de Enfermería de la Universidad del País Vasco, España.
J Am Geriatr Soc
August 2015
Division of Geriatric Medicine and Gerontology, School of Medicine, Johns Hopkins University, Baltimore, Maryland.
A A Case Rep
July 2015
From the Department of Anesthesiology, Mayo Clinic, Rochester, Minnesota.
Perioperative hypoglycemia has been associated with adverse outcomes. Consequently, perioperative monitoring of blood glucose using convenient point-of-care (POC) monitors is frequently used. Although venous or arterial glucose POC testing has been cleared for use in critically ill hospitalized patients, the results of capillary glucose POC testing should be interpreted with caution because capillary POC samples are usually less reliable than those obtained from arterial or venous sites.
View Article and Find Full Text PDFLab Med
May 2016
Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA Clinical Laboratories, University of Pittsburgh Medical Center Presbyterian and Shadyside Hospitals, Pittsburgh, PA McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA
Herein, we present a case of pseudohypoglycemia induced by hypothermia in an 83-year-old white man in whom glucose levels between venous and capillary blood were discrepant. Although pseudohypoglycemia has been reported in the literature, it is under-recognized among health care professionals and laboratorians. Health care professionals may encounter pseudohypoglycemia using glucose meters; the potentially inaccuracy of glucose meter results for critically ill patients has been intensely debated recently.
View Article and Find Full Text PDFAnn Biol Clin (Paris)
September 2010
Laboratoire de biochimie médicale, Service d'endocrinologie-diabétologie-maladies métaboliques, CHU de Clermont-Ferrand.
Mrs B., 39 years old, hospitalized in the department of respiratory medicine for lung cancer, has an undetectable and verified venous blood glucose concentration (measured in central laboratory) less than 0.1 mmol/L.
View Article and Find Full Text PDFEndocr Pract
April 2008
Department of Internal Medicine, University of Cincinnati, College of Medicine, Cincinnati, Ohio 45208, USA.
Objective: To identify patients with an inaccurate diagnosis of hypoglycemia and discuss predisposing factors.
Methods: We describe our patient's clinical presentation, laboratory work-up, hospital course, and follow-up and review similar cases from the literature.
Results: A 27-year-old woman with Raynaud phenomenon was admitted because of symptomatic hypoglycemia.
South Med J
November 1990
Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock 79430.
Four cases of coma, clinically typed as hypoglycaemic but without low blood sugar levels are presented. The clinical picture was rapidly normalised by immediate infusion with hypertonic glucosate. A tentative pathogenetic hypothesis is proposed and the Yager and Young "non-hypoglycaemia" syndrome is once more discussed.
View Article and Find Full Text PDF